GlassScriptPhysician profile
Heather Rowlands
NPI 1366081978
$4,466.48
in general payments reported to CMS, 2019-2025
40 companies · $976 in 2025
The $976 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $530 · 2022: $965 · 2023: $1,000 · 2024: $995 · 2025: $976.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,971.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,971.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $860.00 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $452.27 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $392.27 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $325.82 | 2022-2025 | |
| Alexion Pharmaceuticals, INC. | $244.17 | 2022-2025 | Strensiq |
| Janssen Pharmaceuticals, INC | $232.48 | 2021-2025 | Spravato |
| Novo Nordisk INC | $209.66 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $176.86 | 2022-2024 | |
| Pfizer INC. | $166.27 | 2021-2025 | |
| Abbott Laboratories | $113.35 | 2021-2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $111.38 | 2022-2025 | Arexvy, Bexsero, Shingrix |
| Merck Sharp & Dohme LLC | $95.12 | 2022-2024 | Capvaxive, Gardasil 9, Gardasil |
| Astellas Pharma US INC | $93.18 | 2022-2025 | Veozah, Myrbetriq |
| Exact Sciences Corporation | $87.11 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $77.82 | 2021-2024 | Repatha, Otezla, Evenity |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Rowlands listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.